Show simple item record

FieldValueLanguage
dc.contributor.authorMelov, Sarah Jane
dc.date.accessioned2024-02-29T00:20:04Z
dc.date.available2024-02-29T00:20:04Z
dc.date.issued2024en
dc.identifier.urihttps://hdl.handle.net/2123/32285
dc.descriptionIncludes publication
dc.description.abstractCardiovascular disease is a global leading cause of mortality in women. Pregnancy has been called a ‘stress test’ due to pathological indicators such as gestational diabetes (GDM) that can ‘flag’ increased risk for cardiometabolic disease. Of concern is the global rising prevalence of type 2 diabetes (T2DM) and cardiometabolic disease, with pandemics identified to increase population risk for both. There are measures to reduce cardiometabolic disease risk such as exercise and diet. Breastfeeding has also been identified to reduce T2DM risk, however the impact on next pregnancy GDM risk is unknown. It is also unknown how changes in maternity care during the COVID-19 pandemic impact cardiometabolic risk. The aim of my thesis was to investigate cardiometabolic risk for women during the pandemic with a focus on gestational diabetes and breastfeeding. Quantitative and qualitative studies were undertaken for this thesis. An initial novel quantitative pilot study identified that high intensity breastfeeding (HIBF) was associated with a lower glucose level on the OGTT (published). In my follow-up study of 5,374 participants, HIBF was associated with 47% reduced odds of an abnormal fasting glucose in a subsequent pregnancy OGTT (aOR 0.53; 95%CI 0.38-0.75; p<0.01). A mixed methods approach examined potential influences on cardiometabolic health in the first year of the pandemic during the low COVID-19 prevalence period (three publications). Further qualitative methodology was used to explore the disruption to maternity care and identified disrupted social support and vulnerable groups in the high migrant population. This thesis presents novel findings identifying optimal breastfeeding patterns can have direct metabolic benefits in a subsequent. The results of our COVID-19 research provides unique insights into how service and community changes alone impact obstetric outcomes and potential cardiometabolic risk in a high migrant population.en
dc.language.isoenen
dc.rightsCopyright All Rights Reserveden
dc.subjectbreastfeedingen
dc.subjectcardiovascular diseaseen
dc.subjectdiabetesen
dc.subjectlactationen
dc.subjectpregnancyen
dc.subjectCOVID-19en
dc.titleFlags for future disease: postpartum cardiometabolic risk & prevention by understanding the contribution of breastfeeding and the influences of the COVID-19 pandemicen
dc.typeThesis
dc.type.thesisDoctor of Philosophyen
dc.rights.otherThe author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.en
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Westmead Clinical Schoolen
usyd.degreeDoctor of Philosophy Ph.D.en
usyd.awardinginstThe University of Sydneyen
usyd.advisorPasupathy, Dharmintraen
usyd.include.pubYesen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.